By Katherine Hamilton
Aeluma intends to offer and sell shares of its stock in a public offering. The stock fell 9% to $15.49 after the bell Wednesday.
Arvinas said it was cutting 15% of its workforce as it plans to outsource the licensing for the commercialization of its breast cancer treatment vepdegestrant. Shares declined 3% to $7.40 in after-hours trading.
Red Cat also announced a share offering of its common stock. Shares fell 7% to $10.47.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
September 17, 2025 19:55 ET (23:55 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.